Ro 5212773

CAS No. 1110781-88-8

Ro 5212773( EPPTB | Epptb | Ro 5212773 )

Catalog No. M28628 CAS No. 1110781-88-8

EPPTB is a selective TAAR1 antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 65 Get Quote
10MG 115 Get Quote
25MG 257 Get Quote
50MG 513 Get Quote
100MG 735 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Ro 5212773
  • Note
    Research use only, not for human use.
  • Brief Description
    EPPTB is a selective TAAR1 antagonist.
  • Description
    EPPTB is a selective TAAR1 antagonist.(In Vivo):EPPTB prevents the reduction of the firing frequency of DA neurons induced by p-tyramine (p-tyr), a nonselective TAAR1 agonist. the EPPTB effects were absent in Taar1 knockout mice, ruling out off-target effects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    EPPTB | Epptb | Ro 5212773
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    EGFR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1110781-88-8
  • Formula Weight
    378.39
  • Molecular Formula
    C20H21F3N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (264.28 mM)
  • SMILES
    CCOc1cccc(NC(c(cc2)cc(C(F)(F)F)c2N2CCCC2)=O)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.John Emmerson Campbell, et al. Inhibitors of mutant forms of egfr. Patent WO2021133809A1.
molnova catalog
related products
  • Angiotensin 1 Human

    Angiotensin 1 (Human) is the precursor to the vasoconstrictor peptide angiotensin II, cleaved by the angiotensin-converting enzyme (ACE).Angiotensin is a peptide hormone that causes vasoconstriction and an increase in blood pressure.

  • Artemether

    Artemether is an antimalarial agent used to treat acute uncomplicated malaria.

  • Indecainide

    Indecainide (Ricainid) is a novel antiarrhythmic compound that is carcinogenic and can be used to study chronic stable ventricular arrhythmias secondary to coronary artery disease or cardiomyopathy.